CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus

After bagging a highly anticipated FDA nod Monday, Sanofi and AstraZeneca’s respiratory syncytial virus (RSV) antibody now has a date on a committee's calendar to determine its place in U.S. immunization guidelines.